Plus   Neg

Dentsply Sirona Posts Operating Loss In Q2; Organic Sales Down 49.9% - Quick Facts

Dentsply Sirona Inc. (XRAY) reported a second quarter operating loss per share of $0.18 compared to profit of $0.66, previous year. On average, 15 analysts polled by Thomson Reuters expected the company to report a loss per share of $0.02, for the quarter. Analysts' estimates typically exclude special items.

Second quarter net sales were $491 million, down 51.4% from prior year, impacted by COVID-19. Organic sales declined 49.9%, for the quarter. Analysts expected revenue of $492.55 million for the quarter.

Don Casey, CEO of Dentsply Sirona, said: "The global response to COVID-19 impacted our second quarter results. We have been encouraged to see continued improvement in sales trends, as dental offices reopen and patients return."

As a result of the uncertainty due to COVID-19 pandemic, the company is not providing 2020 guidance.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT